Clinical Study
Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
Table 2
Comparison of topical adverse effects of the four prostaglandins in primary open-angle glaucoma patients controlled by monotherapy.
| | Bimatoprost () | Latanoprost () | Travoprost () | Tafluprost () | value |
| Adverse effect, n (%) | | | | | | Conjunctival hyperemia | 6 (75.0) | 5 (71.4) | 4 (50.0) | 9 (100.0) | 0.13 | Superficial keratitis | 4 (50.0) | 4 (57.1) | 3 (3.8) | 3 (33.3) | 0.76 | Follicular conjunctivitis | 2 (25.0) | 4 (57.1) | 3 (3.8) | 5 (55.5) | 0.51 | Iris hyperpigmentation | 0 (0) | 2 (28.6) | 0 (0) | 0 (0) | 0.05 | Eyelash growth | 1 (12.5) | 4 (57.1) | 2 (25.0) | 0 (0) | 0.05 | Herpetic reactivation | 0 (0) | 1 (14.3) | 0 (0) | 0 (0) | 0.30 |
|
|